CEO, CIO, and Senior Advisors of Aditxt Complete Conversion of ~$1.1 Million in Accrued Compensation into Restricted IPO Units
Loma Linda, CA, July 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), […]